These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8112368)

  • 1. Effect of metoclopramide and loperamide on the pharmacokinetics of didanosine in HIV seropositive asymptomatic male and female patients.
    Knupp CA; Milbrath RL; Barbhaiya RH
    Eur J Clin Pharmacol; 1993; 45(5):409-13. PubMed ID: 8112368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacokinetic interaction study of didanosine coadministered with trimethoprim and/or sulphamethoxazole in HIV seropositive asymptomatic male patients.
    Srinivas NR; Knupp CA; Batteiger B; Smith RA; Barbhaiya RH
    Br J Clin Pharmacol; 1996 Mar; 41(3):207-15. PubMed ID: 8866920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food-induced reduction in bioavailability of didanosine.
    Shyu WC; Knupp CA; Pittman KA; Dunkle L; Barbhaiya RH
    Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):503-7. PubMed ID: 1934863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus.
    Knupp CA; Brater DC; Relue J; Barbhaiya RH
    J Clin Pharmacol; 1993 Oct; 33(10):912-7. PubMed ID: 8227460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of time of food administration on the bioavailability of didanosine from a chewable tablet formulation.
    Knupp CA; Milbrath R; Barbhaiya RH
    J Clin Pharmacol; 1993 Jun; 33(6):568-73. PubMed ID: 8366182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-interaction study of didanosine and ranitidine in patients seropositive for human immunodeficiency virus.
    Knupp CA; Graziano FM; Dixon RM; Barbhaiya RH
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2075-9. PubMed ID: 1444287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiple-dose pharmacokinetic interaction study between didanosine (Videx) and ciprofloxacin (Cipro) in male subjects seropositive for HIV but asymptomatic.
    Knupp CA; Barbhaiya RH
    Biopharm Drug Dispos; 1997 Jan; 18(1):65-77. PubMed ID: 9008270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of co-administered didanosine and stavudine in HIV-seropositive male patients.
    Seifert RD; Stewart MB; Sramek JJ; Conrad J; Kaul S; Cutler NR
    Br J Clin Pharmacol; 1994 Nov; 38(5):405-10. PubMed ID: 7893580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metoclopramide, bethanechol, and loperamide on gastric residence time, gastric emptying, and mouth-to-cecum transit time.
    Kirby MG; Dukes GE; Heizer WD; Bryson JC; Powell JR
    Pharmacotherapy; 1989; 9(4):226-31. PubMed ID: 2771808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patients.
    Sahai J; Gallicano K; Garber G; Pakuts A; Cameron W
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):54-60. PubMed ID: 7648285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in gastrointestinal motility influence the absorption of desmopressin.
    Callréus T; Lundahl J; Höglund P; Bengtsson P
    Eur J Clin Pharmacol; 1999 Jun; 55(4):305-9. PubMed ID: 10424324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cisapride, metoclopramide and loperamide on gastric emptying of normal volunteers as measured by means of the area under the curve of the cumulative fraction absorbed-time profiles of paracetamol.
    van Wyk M; Sommers DK; Moncrieff J
    Methods Find Exp Clin Pharmacol; 1992 Jun; 14(5):379-82. PubMed ID: 1513194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high-dose oral ganciclovir on didanosine disposition in human immunodeficiency virus (HIV)-positive patients.
    Jung D; Griffy K; Dorr A; Raschke R; Tarnowski TL; Hulse J; Kates RE
    J Clin Pharmacol; 1998 Nov; 38(11):1057-62. PubMed ID: 9824788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects.
    Cimoch PJ; Lavelle J; Pollard R; Griffy KG; Wong R; Tarnowski TL; Casserella S; Jung D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):227-34. PubMed ID: 9495222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the plasma pharmacokinetics and renal clearance of didanosine during once and twice daily dosing in HIV-1 infected individuals.
    Hoetelmans RM; van Heeswijk RP; Profijt M; Mulder JW; Meenhorst PL; Lange JM; Reiss P; Beijnen JH
    AIDS; 1998 Dec; 12(17):F211-6. PubMed ID: 9863862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex.
    Knupp CA; Shyu WC; Dolin R; Valentine FT; McLaren C; Martin RR; Pittman KA; Barbhaiya RH
    Clin Pharmacol Ther; 1991 May; 49(5):523-35. PubMed ID: 1903100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children. Pediatric AIDS Clinical Trials Group Protocol 144 Study Team.
    Stevens RC; Rodman JH; Yong FH; Carey V; Knupp CA; Frenkel LM
    AIDS Res Hum Retroviruses; 2000 Mar; 16(5):415-21. PubMed ID: 10772527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of altering small bowel transit time on sustained release theophylline absorption.
    Bryson JC; Dukes GE; Kirby MG; Heizer WD; Powell JR
    J Clin Pharmacol; 1989 Aug; 29(8):733-8. PubMed ID: 2778094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of 2',3'-dideoxyinosine (BMY-40900), a new anti-human immunodeficiency virus agent, after administration of single intravenous doses to beagle dogs.
    Kaul S; Knupp CA; Dandekar KA; Pittman KA; Barbhaiya RH
    Antimicrob Agents Chemother; 1991 Apr; 35(4):610-4. PubMed ID: 1906259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.